April 15, 2019, 07:25 pm

Novavax faces delisting threat following failed drug trial


 15-04-2019 7:25 PM

Nasdaq has warned Novavax Inc. that its stock could be delisted if it can't get the price consistently above a buck within the next six months. The Gaithersburg biotech's stock has fallen below $1 for 30 consecutive days and the company has 180 days - until Oct. 8 - to regain compliance...

Posted in: Tags:
Washington Business Journal
Washington Business Journal

This article was posted online by Washington Business Journal. Spot On Washington DC collects excepts of news articles from this news source and add these in the 'DC Business'-category. For mor einformation about Spot On Washington DC, you can check the About Us-page.

This story was posted in the category: